The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance
Open accessAbstract
Our previous work demonstrated that cytotoxic T lymphocyte (CTL)-mediated tumor immunosurveillance of the 15-12RM tumor could be suppressed by a CD1d-restricted lymphocyte, most likely a natural killer (NK) T cell, which produces interleukin (IL)-13. Here we present evidence for the effector elements in this suppressive pathway. T cell–reconstituted recombination activating gene (RAG)2 knockout (KO) and RAG2/IL-4 receptor α double KO mice showed that inhibition of immunosurveillance requires IL-13 responsiveness by a non–T non–B cell. Such nonlymphoid splenocytes from tumor-bearing mice produced more transforming growth factor (TGF)-β, a potent inhibitor of CTL, ex vivo than such cells from naive mice, and this TGF-β production was dependent on the presence in vivo of both IL-13 and CD1d-restricted T cells. Ex vivo TGF-β production was also abrogated by depleting either CD11b+ or Gr-1+ cells from the nonlymphoid cells of tumor-bearing mice. Further, blocking TGF-β or depleting Gr-1+ cells in vivo prevented the tumor recurrence, implying that TGF-β made by a CD11b+ Gr-1+ myeloid cell, in an IL-13 and CD1d-restricted T cell–dependent mechanism, is necessary for down-regulation of tumor immunosurveillance. Identification of this stepwise regulation of immunosurveillance, involving CD1-restricted T cells, IL-13, myeloid cells, and TGF-β, explains previous observations on myeloid suppressor cells or TGF-β and provides insights for targeted approaches for cancer immunotherapy, including synergistic blockade of TGF-β and IL-13.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Natural selection of tumor variants in the generation of “tumor escape” phenotypes
Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C.-R., Koezuka, Y., & Kronenberg, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.741 · Cited by 887
Zurawski, G., & de Vries, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90021-3 · Cited by 872
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
The unconventional lifestyle of NKT cells
Kronenberg, M., & Gapin, L. (2002) · Nature Reviews Immunology · doi:10.1038/nri854 · Cited by 747
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Self-citationChiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603
Self-citationBronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., & Zanovello, P. (2000) · Blood · doi:10.1182/blood.v96.12.3838 · Cited by 527
Murine CD1d-Restricted T Cell Recognition of Cellular Lipids
Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y., Porcelli, S. A., Cardell, S., Brenner, M. B., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80174-0 · Cited by 469
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215234 · Cited by 415
In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L., & Zern, M. A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2477 · Cited by 415
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Self-citationYang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
Self-citationArteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Flow cytometric identification of murine neutrophils and monocytes
Lagasse, E., & Weissman, I. L. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00138-x · Cited by 338
Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H. F., Henderson, S. L., O'Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · PubMed · Cited by 321
Self-citationBronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., & Ellingsworth, L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1536 · Cited by 293
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
Wu, D. Y., Segal, N. H., Sidobre, S., Kronenberg, M., & Chapman, P. B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030446 · Cited by 279
Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O’Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2317 · Cited by 277
Self-citationTumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Schleifer, K. W., & Mansfield, J. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5492 · Cited by 238
Young, M. R. I., Wright, M. A., Lozano, Y., Matthews, J. P., Benefield, J., & Prechel, M. M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960729)67:3<333::aid-ijc5>3.0.co;2-s · Cited by 180
Angulo, I., de las Heras, F. G., Garcı́a-Bustos, J. F., Gargallo, D., Muñoz-Fernández, M. A., & Fresno, M. (2000) · Blood · doi:10.1182/blood.v95.1.212 · Cited by 161
Mul�, J., Schwarz, S., Roberts, A. B., Sporn, M. B., & Rosenberg, S. (1988) · Cancer Immunology Immunotherapy · doi:10.1007/bf00205600 · Cited by 156
Vitamin A deficiency in mice causes a systemic expansion of myeloid cells
Kuwata, T., Wang, I., Tamura, T., Ponnamperuma, R. M., Levine, R., Holmes, K. L., Morse, H. C., Luca, L. M. D., & Ozato, K. (2000) · Blood · doi:10.1182/blood.v95.11.3349 · Cited by 147
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
Salvadori, S., Martinelli, G. P., & Zier, K. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2214 · Cited by 144
Ostrand‐Rosenberg, S., Grusby, M. J., & Clements, V. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6015 · Cited by 143
Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., & Prechel, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1916 · Cited by 142
Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., & Lee, W. M. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1603 · Cited by 122
Ostrand‐Rosenberg, S., Clements, V. K., Terabe, M., Park, J. M., Berzofsky, J. A., & Dissanayake, S. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5796 · Cited by 112
Self-citationLoke, P., MacDonald, A. S., & Allen, J. E. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<1127::aid-immu1127>3.0.co;2-# · Cited by 106
Kodera, T., McGaha, T. L., Phelps, R. G., Paul, W. E., & Bona, C. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052709999 · Cited by 105
Self-citationPeláez, B., Campillo, J. A., García‐Asenjo, J. A. L., & Subiza, J. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6608 · Cited by 93
Matsui, S., Ahlers, J. D., Vortmeyer, A. O., Terabe, M., Tsukui, T., Carbone, D. P., Liotta, L. A., & Berzofsky, J. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.184 · Cited by 92
Self-citationAhlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. K., & Berzofsky, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192251199 · Cited by 88
Self-citationSuperantigen-Induced CD4 T Cell Tolerance Mediated by Myeloid Cells and IFN-γ
Cauley, L. S., Miller, E., Yen, M., & Swain, S. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6056 · Cited by 87
Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice
Kacha, A. K., Fallarino, F., Markiewicz, M. A., & Gajewski, T. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6024 · Cited by 83
Won, J., Kim, H., Park, E. J., Hong, Y., Kim, S., & Yun, Y. (1999) · PubMed · Cited by 76
Ahlers, J. (2002) · Medical Entomology and Zoology · Cited by 47
Hoefer, M., & Anderer, F. A. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01517218 · Cited by 37
Marshall, M. A., Jankovic, D. L., Maher, V. E., Sher, A., & Berzofsky, J. A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01499-x · Cited by 32
Self-citationTerabe, M., Shimizu, M., Mabuchi, A., Matui, S., Morikawa, H., Kaneda, K., Kakiuchi, T., & Yokomuro, K. (2000) · Hepatology · doi:10.1053/jhep.2000.9875 · Cited by 15
Self-citation
Cited by
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Metadata
- Authors
- Terabe, M., Matsui, S., Park, J.-M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., Letterio, J. J., Paul, W. E., & Berzofsky, J. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-12-01
- Volume
- 198
- Issue
- 11
- Pages
- 1741-1752
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2002801575
- Cited by
- 539
- References
- 47
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.